PortfoliosLab logoPortfoliosLab logo
HRTS vs. PSCH
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

HRTS vs. PSCH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Obesity & Cardiometabolic ETF (HRTS) and Invesco S&P SmallCap Health Care ETF (PSCH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

HRTS vs. PSCH - Yearly Performance Comparison


2026 (YTD)202520242023
HRTS
Tema Obesity & Cardiometabolic ETF
-3.74%23.93%-4.30%14.97%
PSCH
Invesco S&P SmallCap Health Care ETF
-6.37%-0.49%3.77%15.07%

Returns By Period

In the year-to-date period, HRTS achieves a -3.74% return, which is significantly higher than PSCH's -6.37% return.


HRTS

1D
0.84%
1M
-4.98%
YTD
-3.74%
6M
8.13%
1Y
20.39%
3Y*
5Y*
10Y*

PSCH

1D
0.25%
1M
-4.93%
YTD
-6.37%
6M
-1.85%
1Y
-2.33%
3Y*
-1.76%
5Y*
-7.33%
10Y*
6.54%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


HRTS vs. PSCH - Expense Ratio Comparison

HRTS has a 0.75% expense ratio, which is higher than PSCH's 0.29% expense ratio.


Return for Risk

HRTS vs. PSCH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRTS
HRTS Risk / Return Rank: 5353
Overall Rank
HRTS Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
HRTS Sortino Ratio Rank: 5656
Sortino Ratio Rank
HRTS Omega Ratio Rank: 4949
Omega Ratio Rank
HRTS Calmar Ratio Rank: 5757
Calmar Ratio Rank
HRTS Martin Ratio Rank: 4646
Martin Ratio Rank

PSCH
PSCH Risk / Return Rank: 88
Overall Rank
PSCH Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
PSCH Sortino Ratio Rank: 1010
Sortino Ratio Rank
PSCH Omega Ratio Rank: 1010
Omega Ratio Rank
PSCH Calmar Ratio Rank: 77
Calmar Ratio Rank
PSCH Martin Ratio Rank: 66
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HRTS vs. PSCH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Obesity & Cardiometabolic ETF (HRTS) and Invesco S&P SmallCap Health Care ETF (PSCH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HRTSPSCHDifference

Sharpe ratio

Return per unit of total volatility

1.07

-0.10

+1.17

Sortino ratio

Return per unit of downside risk

1.54

0.02

+1.52

Omega ratio

Gain probability vs. loss probability

1.20

1.00

+0.19

Calmar ratio

Return relative to maximum drawdown

1.58

-0.30

+1.89

Martin ratio

Return relative to average drawdown

4.72

-0.75

+5.47

HRTS vs. PSCH - Sharpe Ratio Comparison

The current HRTS Sharpe Ratio is 1.07, which is higher than the PSCH Sharpe Ratio of -0.10. The chart below compares the historical Sharpe Ratios of HRTS and PSCH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


HRTSPSCHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.07

-0.10

+1.17

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.32

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.28

Sharpe Ratio (All Time)

Calculated using the full available price history

0.64

0.49

+0.15

Correlation

The correlation between HRTS and PSCH is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Dividends

HRTS vs. PSCH - Dividend Comparison

HRTS's dividend yield for the trailing twelve months is around 1.39%, more than PSCH's 0.01% yield.


TTM2025202420232022202120202019201820172016
HRTS
Tema Obesity & Cardiometabolic ETF
1.39%1.34%1.63%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PSCH
Invesco S&P SmallCap Health Care ETF
0.01%0.04%0.27%0.01%2.27%0.00%0.00%0.00%0.00%0.00%0.03%

Drawdowns

HRTS vs. PSCH - Drawdown Comparison

The maximum HRTS drawdown since its inception was -25.81%, smaller than the maximum PSCH drawdown of -46.32%. Use the drawdown chart below to compare losses from any high point for HRTS and PSCH.


Loading graphics...

Drawdown Indicators


HRTSPSCHDifference

Max Drawdown

Largest peak-to-trough decline

-25.81%

-46.32%

+20.51%

Max Drawdown (1Y)

Largest decline over 1 year

-11.01%

-15.36%

+4.35%

Max Drawdown (5Y)

Largest decline over 5 years

-46.32%

Max Drawdown (10Y)

Largest decline over 10 years

-46.32%

Current Drawdown

Current decline from peak

-7.25%

-36.16%

+28.91%

Average Drawdown

Average peak-to-trough decline

-9.12%

-13.26%

+4.14%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.69%

6.25%

-2.56%

Volatility

HRTS vs. PSCH - Volatility Comparison

The current volatility for Tema Obesity & Cardiometabolic ETF (HRTS) is 5.94%, while Invesco S&P SmallCap Health Care ETF (PSCH) has a volatility of 8.55%. This indicates that HRTS experiences smaller price fluctuations and is considered to be less risky than PSCH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


HRTSPSCHDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.94%

8.55%

-2.61%

Volatility (6M)

Calculated over the trailing 6-month period

11.02%

14.88%

-3.86%

Volatility (1Y)

Calculated over the trailing 1-year period

19.25%

23.32%

-4.07%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.27%

22.91%

-3.64%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.27%

23.64%

-4.37%